PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
5.51%
Revenue growth 1.25-1.5x 3088.T's 3.69%. Bruce Berkowitz would examine if growth advantage is sustainable.
7.49%
Cost growth above 1.5x 3088.T's 3.55%. Michael Burry would check for structural cost disadvantages.
-2.33%
Gross profit decline while 3088.T shows 4.04% growth. Joel Greenblatt would examine competitive position.
-7.43%
Margin decline while 3088.T shows 0.33% expansion. Joel Greenblatt would examine competitive position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-6.00%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
-1.33%
Both companies reducing operating expenses. Martin Whitman would check industry trends.
6.07%
Total costs growth above 1.5x 3088.T's 2.27%. Michael Burry would check for inefficiency.
No Data
No Data available this quarter, please select a different quarter.
-5.91%
D&A reduction while 3088.T shows 5.88% growth. Joel Greenblatt would examine efficiency.
-4.92%
EBITDA decline while 3088.T shows 37.57% growth. Joel Greenblatt would examine position.
-9.89%
EBITDA margin decline while 3088.T shows 32.68% growth. Joel Greenblatt would examine position.
-5.57%
Operating income decline while 3088.T shows 41.55% growth. Joel Greenblatt would examine position.
-10.51%
Operating margin decline while 3088.T shows 36.51% growth. Joel Greenblatt would examine position.
2.64%
Other expenses growth while 3088.T reduces costs. John Neff would investigate differences.
-4.93%
Pre-tax income decline while 3088.T shows 38.32% growth. Joel Greenblatt would examine position.
-9.90%
Pre-tax margin decline while 3088.T shows 33.40% growth. Joel Greenblatt would examine position.
-4.57%
Tax expense reduction while 3088.T shows 32.04% growth. Joel Greenblatt would examine advantage.
-5.25%
Net income decline while 3088.T shows 41.57% growth. Joel Greenblatt would examine position.
-10.20%
Net margin decline while 3088.T shows 36.53% growth. Joel Greenblatt would examine position.
-5.25%
EPS decline while 3088.T shows 38.06% growth. Joel Greenblatt would examine position.
-5.25%
Diluted EPS decline while 3088.T shows 38.06% growth. Joel Greenblatt would examine position.
-0.00%
Share count reduction while 3088.T shows 0.00% change. Joel Greenblatt would examine strategy.
-0.00%
Diluted share reduction while 3088.T shows 0.00% change. Joel Greenblatt would examine strategy.